Reference health

Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multi-Center Observational

https://doi.org/10.2139/ssrn.4113133
CiteStamped reference-health badge
21/21 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 21 checked references that resolve
resolves10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
resolves10.1002/cac2.12220
A global assessment of recent trends in gastrointestinal cancer and lifestyle‐associated risk factors
resolves10.1136/gutjnl-2020-321600
Global burden of oesophageal and gastric cancer by histology and subsite in 2018
resolves10.6004/jnccn.2019.0033
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
resolves10.6004/jnccn.2016.0137
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
resolves10.1016/S0140-6736(20)31288-5
Gastric cancer
resolves10.1200/JCO.2010.33.0597
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
resolves10.1056/NEJMoa055531
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
resolves10.1016/S0140-6736(18)32557-1
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
resolves10.1002/cac2.12193
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
resolves10.5230/jgc.2019.19.e8
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
resolves10.1056/NEJMoa072252
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
resolves10.1016/S0140-6736(11)61873-4
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
resolves10.1046/j.1365-2168.1998.00940.x
Classification of adenocarcinoma of the oesophagogastric junction
resolves10.1053/j.jfas.2017.01.013
Propensity Score Matching: Retrospective Randomization?
resolves10.1016/j.jtcvs.2007.03.034
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma
resolves10.1016/j.soc.2006.07.015
Adenocarcinoma of the Esophagogastric Junction: Surgical Therapy Based on 1602 Consecutive Resected Patients
resolves10.1200/JCO.2003.12.095
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204
resolves10.1007/s10120-018-0890-2
Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China
resolves10.1007/s10120-016-0601-9
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project
resolves10.1245/s10434-017-6078-x
Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database
The 1 reference without a DOI — listed, not checked
no DOI — not checkedJapanese Gastric Cancer A. Japanese gastric cancer treatment guidelines
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2139/ssrn.4113133"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4113133/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2139/ssrn.4113133/badge.svg)](https://citestamp.com/citestamped/10.2139/ssrn.4113133)